Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.406,60
0,11%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Australia ASX Brumby Res Fpo (BMY) Brumby Res Fpo (BMY) Notizie

BMY

Brumby Resources (BMY)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:ASX:BMY
DataOraFonteTitoloSimboloCompagnia
16/10/200922:56Dow Jones NewsUPDATE: Bristol-Myers Cuts Abilify Sales Force By About 25%NYSE:BMYBristol-Myers Squibb Co.
16/10/200915:29Dow Jones NewsBristol-Myers Reduces Abilify Sales Force By About 25%NYSE:BMYBristol-Myers Squibb Co.
05/10/200917:04Dow Jones NewsEU OKs AstraZeneca, Bristol Diabetes Drug For MarketingNYSE:BMYBristol-Myers Squibb Co.
05/10/200916:23Dow Jones NewsAstraZeneca: Onglyza EU Marketing AuthorisationNYSE:BMYBristol-Myers Squibb Co.
02/10/200911:45Dow Jones NewsAstraZeneca Reports Phase III Success For DapagliflozinNYSE:BMYBristol-Myers Squibb Co.
01/10/200922:48Dow Jones NewsDiabetes Drug From Astra, Bristol Shows Benefit In StudyNYSE:BMYBristol-Myers Squibb Co.
29/09/200922:14Dow Jones NewsUPDATE: Danone Denies Speculation Regarding Mead JohnsonNYSE:BMYBristol-Myers Squibb Co.
23/09/200916:22Dow Jones NewsConflicting Erbitux Study Data Hurts Merck SharesNYSE:BMYBristol-Myers Squibb Co.
23/09/200915:22Dow Jones NewsErbitux Succeeds In One Trial, Disappoints In AnotherNYSE:BMYBristol-Myers Squibb Co.
23/09/200911:59Dow Jones NewsMerck Shares Rise On Positive Erbitux Data For Colon CancerNYSE:BMYBristol-Myers Squibb Co.
21/09/200920:52Dow Jones NewsUPDATE:Lilly Drug Launch Seen Sluggish But CFO Sees ProgressNYSE:BMYBristol-Myers Squibb Co.
21/09/200920:28Dow Jones NewsLilly Drug Launch Seen Sluggish But CFO Says Progress MadeNYSE:BMYBristol-Myers Squibb Co.
17/09/200915:31Dow Jones NewsMerck KGaA's Erbitux Data May Be Upstaged By Rival VectibixNYSE:BMYBristol-Myers Squibb Co.
16/09/200906:29Dow Jones NewsUPDATE:Taisho To Buy Bristol-Myers Asian OTC Assets For $310 MillionNYSE:BMYBristol-Myers Squibb Co.
16/09/200905:00Dow Jones NewsTaisho Pharma: To Acquire Bristol-Myers OTC Rights In AsiaNYSE:BMYBristol-Myers Squibb Co.
08/09/200923:11Dow Jones News3rd UPDATE:Facet Again Shuns Biogen Offer, Adopts Poison PillNYSE:BMYBristol-Myers Squibb Co.
08/09/200919:08Dow Jones News2nd UPDATE:Facet Again Shuns Biogen Offer, Adopts Poison PillNYSE:BMYBristol-Myers Squibb Co.
08/09/200917:40Dow Jones NewsUPDATE: Facet Again Shuns Biogen Offer, Adopts Poison PillNYSE:BMYBristol-Myers Squibb Co.
31/08/200912:30Dow Jones NewsStudy: Popular Heartburn Drugs Don't Interfere With PlavixNYSE:BMYBristol-Myers Squibb Co.
30/08/200908:30Dow Jones NewsHigh-Dose Plavix Misses Goal But Helps Some In StudyNYSE:BMYBristol-Myers Squibb Co.
28/08/200920:59Dow Jones NewsUS EQUITIES WEEK AHEAD: Aug Jobs Data, Auto, Retail Sales DueNYSE:BMYBristol-Myers Squibb Co.
28/08/200917:46Dow Jones NewsUPDATE: Boehringer's Blood-Thinner May Edge Out Bayer'sNYSE:BMYBristol-Myers Squibb Co.
28/08/200912:57Dow Jones NewsBoehringer Ingelheim's Blood-Thinner May Edge Out Bayer'sNYSE:BMYBristol-Myers Squibb Co.
25/08/200923:12Dow Jones NewsUPDATE: Study: Plavix Less Effective In Certain PatientsNYSE:BMYBristol-Myers Squibb Co.
25/08/200922:30Dow Jones NewsJAMA Study Shows Plavix Ineffective In Certain PatientsNYSE:BMYBristol-Myers Squibb Co.
20/08/200923:42Dow Jones NewsBristol-Myers Squibb Extends Medarex Tender Offer DeadlineNYSE:BMYBristol-Myers Squibb Co.
19/08/200901:53Dow Jones NewsPreliminary Approval Given To Bristol-Myers Holder PactsNYSE:BMYBristol-Myers Squibb Co.
18/08/200922:51Dow Jones News2nd UPDATE: US Patent Office Orders Re-Exam Of Plavix PatentNYSE:BMYBristol-Myers Squibb Co.
18/08/200919:06Dow Jones NewsUPDATE: US Patent Office Orders Re-Exam Of Plavix PatentNYSE:BMYBristol-Myers Squibb Co.
18/08/200917:41Dow Jones NewsUS Patent Office Orders Re-Examination Of Plavix PatentNYSE:BMYBristol-Myers Squibb Co.
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:ASX:BMY

La tua Cronologia

BIT
S24899
SG ISSUER
BOV
TSMC34
Taiwan Semiconductor Man...
USOTC
FDTC
FNDS 3000 (CE)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network